chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain at injection site; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 21Apr2021 at 12:45 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included losartan (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN), colecalciferol (VITAMIN D3) and zinc (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 31Mar2021 at 12:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 20:00, the patient experienced pain at injection site. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pain at injection site was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Rash, Rash pruritic, Skin warm
Clinical narrative: My arm is red; I have a bump; I have a bump, it is itchy and hot; I have a bump, it is itchy and hot; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 16Apr2021 at 09:30 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and the patient reported that "I can't have NSAIDS" (known allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine sodium (LEVOTHYROXIN), cetirizine hydrochloride (ZYRTEC) and ascorbic acid (VITAMIN C) and unspecified vitamins; all for unspecified indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 26Mar2021 at 09:30 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 17Apr2021 at 10:00, the patient's arm was red and had a bump, it was itchy and hot. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm was red and had a bump, it was itchy and hot was not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Soreness in arm; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ERO729) via an unspecified route of administration in the left arm on 06Apr2021 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on an unknown date in Mar2021 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021 at 14:00, the patient experienced soreness in arm and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with Tylenol. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events soreness in arm and headache was recovered on an unknown date in Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Feeling tingly just not right; This is a spontaneous report from a contactable nurse. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an intramuscular route of administration in the left arm on 22Apr2021 at 11:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medication included diphenhydramine hydrochloride (BENADRYL) from an unknown date for an unknown indication and unknown if ongoing. On 22Apr2021 at 12:00, the patient complained of (c/o) feeling tingly just not right. The patient had no shortness of breath (sob) or any other allergic reaction. The symptoms resolved without (w/o) intervention. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported event. The clinical outcome of event  feeling tingly just not right was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Vaccination site mass
Clinical narrative: she had a mass underneath her left arm; sore muscle sand such; This is a spontaneous report from a contactable reporter (patient). A 59-years-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 20Apr2021 as dose 2, single in the left arm for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on unspecified date as dose 1, single for covid-19 immunisation. On Apr2021, the patient experienced sore muscle sand such and on 22Apr2021 she had a mass underneath her left arm that was not there two days ago, and states that this is the same arm that she received her injection in. The outcome of the events was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Limb discomfort, Mass excision, Pain in extremity
Clinical narrative: she had a mass underneath her left arm; sore muscle sand such; This is a spontaneous report from a contactable reporter (patient). A 59-years-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 20Apr2021 as dose 2, single in the left arm for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on unspecified date as dose 1, single for covid-19 immunisation. On Apr2021, the patient experienced sore muscle sand such and on 22Apr2021 she had a mass underneath her left arm that was not there two days ago, and states that this is the same arm that she received her injection in. The outcome of the events was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Oropharyngeal pain
Clinical narrative: Sore throat; headache; tiredness; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0171) via an unspecified route of administration in the arm left on 21Apr2021 at 16:30 (at the age of 19-year-old) as a single dose for COVID-19 immunisation. The medical history included allergy to penicillin and sulfa drug. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. On 22Apr2021 at 14:00, the patient experienced sore throat, headache and tiredness. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore throat, headache and tiredness was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Headache
Clinical narrative: Weak; Headaches; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 17Apr2021 at 10:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included thalassemia minor and cervical dystonia. The patient had known allergies to mushrooms. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the right arm on 27Mar2021 at 12:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously took cefalexin (KEFLEX) and ciprofloxacin (CIPRO) for unknown indication on an unknown date and experienced drug allergy. On 18Apr2021 at 19:00, the patient experienced weak, headaches and tiredness. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of events weak, headaches and tiredness were resolving at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Thyroid function test, Thyroid function test abnormal
Clinical narrative: thyroid levels had gone up to 4.98; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the right arm on 12Mar2021 at 12:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, high blood pressure and mitral valve prolapse. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no allergies to medications, food, or other products. Concomitant medications included losartan (MANUFACTURER UNKNOWN) and metoprolol (MANUFACTURER UNKNOWN); both from unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 13:15, three weeks after receiving the second shot, the patient underwent blood work because of physical coming up. On the day of the blood draw doctor told him that the thyroid levels had gone up to 4.98 (unspecified units) and put the patient on levothyroxine to lower. The patient had planned to retest in 6 weeks. The previous reading of the patient was 2.86 (unspecified units) on 19Nov2019. The patient reported that he did not have history of hypothyroidism, so found this to be strange. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event and included treatment with levothyroxine. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event thyroid levels had gone up to 4.98 was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Sore arm; Slight headache; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 15Apr2021 at 10:45 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included vitamin d nos (MANUFACTURER UNKNOWN), vitamin b complex (VITAMIN B), ascorbic acid, colecalciferol, zinc citrate, allium sativum bulb, sambucus nigra fruit, piper nigrum fruit, echinacea purpurea whole plant (IMMUNETI), fexofenadine hydrochloride (ALLEGRA) and probiotic (MANUFACTURER UNKNOWN); all from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 25Mar2021 at 15:00 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. On 15Apr2021, the patient experienced sore arm and slight headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with ibuprofen (ADVIL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm and slight headache were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness postural, Nausea
Clinical narrative: Nausea; Dizzy when standing, versus within normal limits; This is a spontaneous report from a contactable nurse. A 54-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an intramuscular route of administration in the left arm on 22Apr2021 at 11:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included depression. The patient had no known drug allergies. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 22Apr2021 at 11:45, the patient experienced nausea and dizzy when standing, versus within normal limits (wnl). The events resulted in emergency room/department visit or urgent care. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the events nausea and dizzy when standing, versus within normal limit was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Iritis
Clinical narrative: My idiopathic iritis has been flaring up non-stop since my shot.; My idiopathic iritis has been flaring up non-stop since my shot.; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 14:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included idiopathic iritis and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included full spectrum cannabidiol (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 07:00 the idiopathic iritis had been flaring up non-stop since his shot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of idiopathic iritis and included treatment with Durezol. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event idiopathic iritis was not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoacusis, Tinnitus
Clinical narrative: Tinnitus in left ear. Persistent ringing as well as distortion of hearing. Symptoms first appeared 4 days after injection.; Tinnitus in left ear. Persistent ringing as well as distortion of hearing. Symptoms first appeared 4 days after injection.; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ewo153) via an unspecified route of administration in the left arm on 10Apr2021 at 15:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient previously took amoxicillin; clavulanic acid (AUGMENTIN) for unknown indication on unknown date and experienced drug allergy. The patient did not receive any concomitant medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced tinnitus in left ear. Persistent ringing as well as distortion of hearing. Symptoms first appeared on 14Apr2021 at 08:00, four days after injection. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of tinnitus in left ear, persistent ringing as well as distortion of hearing and included treatment with Prednisone 60milligram daily. The clinical outcome of the events tinnitus in left ear, persistent ringing as well as distortion of hearing was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: Still hurts on the second day after the vaccine but not swollen.; Right hand was swollen and hard to make a fist.; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP8735) via an unspecified route of administration in the right arm on 20Apr2021(at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included stroke. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included prasugrel (MANUFACTURER UNKNOWN), acetylsalicylic acid, ascorbic acid (ASPIRIN), bupropion hydrochloride (WELLBUTRIN) and chlortalidone (MANUFACTURER UNKNOWN); all for unknown indication and start date. The patient had no allergies to food, medication or other products. The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 30Mar2021 at 11:30 as a single dose for COVID-19 immunisation. The patient got shot on the right arm and on the next day, on 21Apr2021 at 08:00, her right hand was swollen and hard to make a fist. Still hurt on the second day after the vaccine but not swollen. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event right hand was swollen and hard to make a fist and still hurt on the second day after the vaccine but not swollen was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Diplopia
Clinical narrative: Woke up with double vision in right eye.; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 08Apr2021 at 14:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and anxiety. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN) and nortriptyline (MANUFACTURER UNKNOWN); both for unknown indication and start date. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and experienced drug allergy. On 09Apr2021 at 10:00, the patient woke up with double vision in right eye. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event woke up with double vision in right eye was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Feeling abnormal, Headache, Vaccination site pain
Clinical narrative: Brain fog; Soreness at injection site; Soreness at shoulder; Headache; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 07Apr2021 at 12:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder (ADHD) and penicillin allergy. Concomitant medications included lisdexamfetamine mesilate (VYVANSE), ethinylestradiol; norgestrel (CRYSELLE) and cetirizine hydrochloride (ZYRTEC). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced brain fog, soreness at injection site and shoulder, headache and tiredness. The events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of reported events. The clinical outcome of the events brain fog, soreness at injection site and shoulder, headache and tiredness was resolved on an unspecified date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Nausea, Pain, Vertigo
Clinical narrative: Developed Vertigo next day. Vertigo lasted 4 days.; Achy and sore, whole right side sore, from ear to hip; Dizziness; Exhaustion/tired. Exhaustion lasted 6 days, still wiped out.; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 14Apr2021 at 10:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, diabetes and high cholesterol. The patient had known allergies to potatoes. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 11Mar2021 at 10:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 19:00, the patient experienced tired, achy and sore, whole right side sore from ear to hip, dizziness, exhaustion and nausea. On 15Apr2021, the patient experienced vertigo that lasted 4 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vertigo was resolved on 19Apr2021, after the duration of 4 days. The clinical outcome of the events tired, achy and sore, whole right side sore from ear to hip, dizziness, exhaustion and nausea was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Still have a headache after 5 days; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 17Apr2021 at 11:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. Concomitant medications included meloxicam (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN); all taken for an unknown indication from an unknown date and unknown if it is ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 20Mar2021 at 11:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient also received hydrocodone (MANUFACTURER UNKNOWN) and tramadol (MANUFACTURER UNKNOWN); for an unknown indication initiated on an unknown date and experienced drug allergy. On 18Apr2021, it was reported that the patient still had a headache after 5 days. The event did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of event still have a headache after 5 days was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pharyngitis streptococcal
Clinical narrative: I have strep sore throat symptoms. It hurt to eat, talk, and swallow.; got the shot on 04/15/2021 and notice my throat pain on 04/17/2021.; This is a spontaneous report from a contactable other healthcare professional, the patient. A 65-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 14:00 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. The patient had unspecified medical history. The patient received unspecified concomitant medications within 2 weeks of vaccination. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021, the patient experienced strep sore throat symptoms. It hurt to eat, talk, and swallow. He got the shot on 15Apr2021 and noticed his throat pain on 17Apr2021. It was unknown if therapeutic measures were taken as a result of the event. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event strep sore throat symptoms and throat pain were not recovered at the time of the report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Injection arm has tingly feeling like its fallen asleep or like carpal tunnel.; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 20Apr2021 at 16:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 09:00, the patient's injection arm had tingly feeling like it was fallen asleep or like carpal tunnel. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event injection arm has tingly feeling like its fallen asleep or like carpal tunnel was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Paraesthesia oral, Vaccination site mass
Clinical narrative: Tingly mouth; Tired; Lump on arm where the injection was; This is a spontaneous report from a non-contactable consumer. An adult non-pregnant female patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was unknown if the patient had received any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in 2021, after the first dose of COVID vaccine, the patient had a tingly mouth, tired, and lump on arm where the injection was given. All the side effects resolved within 48 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the reported events. The clinical outcome of the events tingly mouth, tired, and lump on arm where the injection was given were recovered within 48 hours on an unknown date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: Experienced body aches; Tired; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 20Apr2021 at 16:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included controlled hypertension. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN) 5 mg by mouth (PO) four times in a day (QD) and losartan (MANUFACTURER UNKNOWN) 50 mg by mouth (PO) four times in a day (QD) all from an unknown date for an unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL8982) via an unspecified route of administration in the left arm on 30Mar2021 at 15:45 as a single dose for COVID-19 immunisation. On 21Apr2021 at 06:00, next morning following second dose the patient experienced body aches and was tired. This lasted for approximately 6 hours, by that evening was back to base line. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches and was tired recovered on 21Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: Have a bump/ tender spot on collarbone; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the right arm on 17Apr2021 at 09:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included heart condition supraventricular tachycardia, allergy to latex and penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified prescription medication for unknown indication on unknown date and unknown if ongoing. On 19Apr2021 at 09:00, 2 days after getting the second shot of vaccine, the patient noticed a bump/ tender spot on collarbone. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event bump/ tender spot-on collarbone was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain
Clinical narrative: A throbbing sharp jabbing pain on right side of head..A jolt throb next to ear and moves to back of head; A throbbing sharp jabbing pain on right side of head..A jolt throb next to ear and moves to back of head; This is a spontaneous report from a non-contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 29Mar2021 at 08:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 09:00, the patient experienced a throbbing sharp jabbing pain on right side of head and a jolt throb next to ear and moves to back of head, started 3 days before second shot. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event a throbbing sharp jabbing pain on right side of head and a jolt throb next to ear and moves to back of head was not recovered at the time of this report. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 08:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Completely achy all over from fingertips to toes- all joints; This is a spontaneous report from a non-contactable consumer. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 02Apr2021 at 14:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy.  Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown whether the patient had received any other vaccines within four weeks prior to the vaccination. It was unknown whether the patient had taken any concomitant medications within two weeks. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation.  On 03Apr2021 at 07:30, the patient experienced completely achy all over from fingertips to toes- all joints. Therapeutic measure was taken as a result of the event completely achy all over from fingertips to toes- all joints and included treatment with Tylenol. Since the vaccination, the patient had not been tested for COVID-19.The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events- completely achy all over from fingertips to toes- all joints was recovered on an unknown date in Apr2021.   No follow-up attempts are possible. No further information is expected
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Product use issue
Clinical narrative: Improper handling of vaccines; Sore arm; Felt tired; This is a spontaneous report from a non-contactable consumer, the parent. A 17-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 01Apr2021 at 16:00 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. On an unknown date in Apr2021, the patient experienced a sore arm and felt tired after the first shot. The clinic where the patient took the first shot was put on evaluation pause to give vaccines due to improper handling of the vaccines. The reporter learned it in the newspaper and could not find more details. The local health department had recommended them to consider the patient's first shot invalid and asked to retake it. The patient had scheduled to take the second shot on 23Apr2021, at another clinic and the nurse there said they could discuss it when they were there whether the patient should take vaccine on 23Apr2021 (Friday) as a first or second shot. They were concerned about overdose or if it was necessary to re-do the first shot and should just treat the 23Apr2021 shot as the second shot. The reporter had requested for an advice. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm and felt tired were unknown at the time of the report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Pain, Vaccination site pain
Clinical narrative: Body aches in the morning; Soreness at site; Fatigue; Some nausea; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 13:15 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included shrimp allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included multivitamin (MANUFACTURER UNKNOWN) on unknown date for unknown indication and unknown if ongoing. On 10Apr2021 at 13:45, first day, the patient experienced soreness at site, fatigue and some nausea. On 12Apr2021 third day, the patient experienced body aches in the morning. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events soreness at site, fatigue, some nausea and body aches in the morning was resolved on an unknown date in Apr2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Lymphadenopathy, Pain, Pyrexia
Clinical narrative: Fever; Chills; Soreness; Swollen lymph nodes; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Apr2021 at 13:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unknown blood pressure medication and vitamins both for unknown indication and form unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 19Mar2021 at 16:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 18:30 the patient experienced fever, chills, soreness, swollen lymph nodes and fatigue. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events fever, chills, soreness, swollen lymph nodes and fatigue were not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Hepatomegaly, Liver function test, Physical examination
Clinical narrative: On exam today She had hepatomegaly.; Fatigue; Weakness; This is a spontaneous report from a contactable physician. A non-pregnant female patient of unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021, as a single dose for COVID-19 immunisation. Medical history included seasonal allergies. Prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date the patient experienced fatigue and weakness after vaccination. On the day of the report, upon physical examination, the patient had hepatomegaly. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in 2021, the patient underwent the lab tests and the test results revealed iron deficiency anemia and leukocytosis, the work up for which was ongoing. The most recent lab results. 2.5 months after vaccination, revealed persistent leukocytosis. iron deficiency anemia, elevated platelets, elevated alkaline phosphatase, elevated GOT (glutamic oxaloacetic transaminase) and elevated platelets. The clinical outcome of the event weakness and fatigue was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.